Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Avidity Biosciences, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $92.2 Billion
- Q3 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 8,913 shares of RNA stock, worth $309,102. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,913
Previous 9,757
8.65%
Holding current value
$309,102
Previous $398,000
2.76%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RNA
# of Institutions
249Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$369 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$320 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$299 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$282 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$244 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.81B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...